Literature DB >> 29656665

Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.

Wilson M Compton1, Beth Han1, Carlos Blanco1, Kimberly Johnson1, Christopher M Jones1.   

Abstract

OBJECTIVE: The authors sought to simultaneously examine the prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse in the U.S. adult population.
METHOD: This was a nationally representative household population study of adults age 18 or older from the 2015 and 2016 National Surveys on Drug Use and Health (N=102,000). Measurements included prescription stimulant use, use without misuse, misuse without use disorders, and misuse with use disorders, as well as sociodemographic characteristics, health conditions, and mental health factors.
RESULTS: Among U.S. adults, 6.6% (annual average) used prescription stimulants overall; 4.5% used without misuse, 1.9% misused without use disorders, and 0.2% had use disorders. Adults with past-year prescription stimulant use disorders did not differ from those with misuse without use disorders in any of the examined sociodemographic characteristics and in many of the examined substance use problems. The most commonly reported motivations for misuse were to help be alert or concentrate (56.3%). The most likely source of misused prescription stimulants was by obtaining them free from friends or relatives (56.9%). More frequent prescription stimulant misuse and use disorder were associated with an increased likelihood of obtaining medications from physicians or from drug dealers or strangers and less likelihood of obtaining them from friends or relatives.
CONCLUSIONS: Approximately 16.0 million U.S. adults used prescription stimulants in the preceding year (annual average), 5.0 million misused prescription stimulants, and 0.4 million had use disorders. Cognitive enhancement was the most commonly reported reason for misusing prescription stimulants. Patients who are using their medication for cognitive enhancement or diverting their medication to others present a high risk.

Entities:  

Keywords:  CNS Stimulants; Epidemiology; Psychoactive Substance Use Disorder

Mesh:

Substances:

Year:  2018        PMID: 29656665      PMCID: PMC6070393          DOI: 10.1176/appi.ajp.2018.17091048

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  31 in total

1.  Stimulant medication use in children: a 12-year perspective.

Authors:  Samuel H Zuvekas; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

2.  The structure of common mental disorders.

Authors:  R F Krueger
Journal:  Arch Gen Psychiatry       Date:  1999-10

3.  Physician practices to prevent ADHD stimulant diversion and misuse.

Authors:  Natalie Colaneri; Sarah Keim; Andrew Adesman
Journal:  J Subst Abuse Treat       Date:  2016-12-21

4.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

5.  Motivations for non-medical prescription drug use: a mixed methods analysis.

Authors:  Khary K Rigg; Gladys E Ibañez
Journal:  J Subst Abuse Treat       Date:  2010-07-29

6.  The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.

Authors:  Saul Shiffman; Andrew Waters; Mary Hickcox
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

7.  Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond.

Authors:  Sean Esteban McCabe; Carol J Boyd; James A Cranford; Christian J Teter
Journal:  Arch Pediatr Adolesc Med       Date:  2009-08

8.  Motivational subtypes of nonmedical use of prescription medications: results from a national study.

Authors:  Sean Esteban McCabe; James A Cranford
Journal:  J Adolesc Health       Date:  2012-04-05       Impact factor: 5.012

9.  Everyday drug diversions: a qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus.

Authors:  Scott Vrecko
Journal:  Soc Sci Med       Date:  2014-10-07       Impact factor: 4.634

10.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

View more
  45 in total

1.  Motivations for the nonmedical use of prescription drugs in a longitudinal national sample of young adults.

Authors:  Tess K Drazdowski; Lourah M Kelly; Wendy L Kliewer
Journal:  J Subst Abuse Treat       Date:  2020-04-29

2.  Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.

Authors:  Zheng Chang; Patrick D Quinn; Lauren O'Reilly; Arvid Sjölander; Kwan Hur; Robert Gibbons; Henrik Larsson; Brian M D'Onofrio
Journal:  Biol Psychiatry       Date:  2019-12-13       Impact factor: 13.382

Review 3.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

4.  Prescription Stimulant Use and Misuse: Implications for Responsible Prescribing Practices.

Authors:  Amelia M Arria; Robert L DuPont
Journal:  Am J Psychiatry       Date:  2018-08-01       Impact factor: 18.112

5.  Opioid-involved prescription drug misuse and poly-prescription drug misuse in U.S. older adults.

Authors:  Ty S Schepis; Jason A Ford; Linda Wastila; Sean Esteban McCabe
Journal:  Aging Ment Health       Date:  2020-11-02       Impact factor: 3.658

Review 6.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

7.  Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments.

Authors:  Alana M Vivolo-Kantor; Brooke E Hoots; Puja Seth; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

8.  Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.

Authors:  Sean Esteban McCabe; Timothy E Wilens; Carol J Boyd; Kao-Ping Chua; Terri Voepel-Lewis; Ty S Schepis
Journal:  Addict Behav       Date:  2018-11-14       Impact factor: 3.913

9.  Stimulant Medication Prescribing Practices Within a VA Health Care System.

Authors:  Caroline Richmond; Justin Butler
Journal:  Fed Pract       Date:  2020-02

10.  Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.

Authors:  Amy R Board; Gery Guy; Christopher M Jones; Brooke Hoots
Journal:  Drug Alcohol Depend       Date:  2020-09-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.